PMC:7313968 / 0-168 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T1","span":{"begin":43,"end":55},"obj":"Body_part"},{"id":"T2","span":{"begin":93,"end":105},"obj":"Body_part"},{"id":"T3","span":{"begin":147,"end":155},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"fma_id","subj":"T1","obj":"http://purl.org/sig/ont/fma/fma62925"},{"id":"A2","pred":"fma_id","subj":"T2","obj":"http://purl.org/sig/ont/fma/fma82784"},{"id":"A3","pred":"fma_id","subj":"T3","obj":"http://purl.org/sig/ont/fma/fma62871"}],"text":"Identification of 22 N-glycosites on spike glycoprotein of SARS-CoV-2 and accessible surface glycopeptide motifs: implications for vaccination and antibody therapeutics"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T1","span":{"begin":59,"end":67},"obj":"Disease"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"Identification of 22 N-glycosites on spike glycoprotein of SARS-CoV-2 and accessible surface glycopeptide motifs: implications for vaccination and antibody therapeutics"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T1","span":{"begin":18,"end":20},"obj":"http://purl.obolibrary.org/obo/CLO_0050507"}],"text":"Identification of 22 N-glycosites on spike glycoprotein of SARS-CoV-2 and accessible surface glycopeptide motifs: implications for vaccination and antibody therapeutics"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T1","span":{"begin":43,"end":55},"obj":"Chemical"},{"id":"T2","span":{"begin":93,"end":105},"obj":"Chemical"}],"attributes":[{"id":"A1","pred":"chebi_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/CHEBI_17089"},{"id":"A2","pred":"chebi_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/CHEBI_24396"}],"text":"Identification of 22 N-glycosites on spike glycoprotein of SARS-CoV-2 and accessible surface glycopeptide motifs: implications for vaccination and antibody therapeutics"}

{"project":"LitCovid-PubTator","denotations":[{"id":"4","span":{"begin":37,"end":42},"obj":"Gene"},{"id":"5","span":{"begin":59,"end":69},"obj":"Species"},{"id":"6","span":{"begin":21,"end":22},"obj":"Chemical"},{"id":"7","span":{"begin":93,"end":105},"obj":"Chemical"}],"attributes":[{"id":"A4","pred":"tao:has_database_id","subj":"4","obj":"Gene:43740568"},{"id":"A5","pred":"tao:has_database_id","subj":"5","obj":"Tax:2697049"},{"id":"A6","pred":"tao:has_database_id","subj":"6","obj":"MESH:D009584"},{"id":"A7","pred":"tao:has_database_id","subj":"7","obj":"MESH:D006020"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Identification of 22 N-glycosites on spike glycoprotein of SARS-CoV-2 and accessible surface glycopeptide motifs: implications for vaccination and antibody therapeutics"}

{"project":"LitCovid-sentences","denotations":[{"id":"T1","span":{"begin":0,"end":168},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Identification of 22 N-glycosites on spike glycoprotein of SARS-CoV-2 and accessible surface glycopeptide motifs: implications for vaccination and antibody therapeutics"}